Retail News Breaks Archives

Week of Mon, Jun 8th, 2009

CVS applauds FTC report on biologics competition

CVS Caremark Corp. gave kudos to a new Federal Trade Commission report that calls for the creation of an efficient pathway for bringing follow-on biologic (FOB) drugs to market, in turn making biologics more affordable for consumers.

Rx groups file suit against Delaware Medicaid cuts

The National Association of Chain Drug Stores and the National Community Pharmacists Association have filed a lawsuit challenging rate cuts by the state of Delaware for Medicaid reimbursement for brand-name prescription drugs.

McDonald named CEO of Procter & Gamble

Procter & Gamble Co. on Wednesday said Robert McDonald has been elected president and chief executive officer. He takes over the CEO post from A.G. Lafley, who is slated to move full-time into his role as chairman.

NACDS, FMI file principal arguments in AWP lawsuit

Challenging the First DataBank and Medi-Span settlements that reduce average wholesale prices (AWPs) for prescription drugs, the National Association of Chain Drug Stores and the Food Marketing Institute have filed their principal legal brief with the U.S. Court of Appeals for the First Circuit.

Health Enterprises products earn American Podiatric seal

Health Enterprises Inc. has received the American Podiatric Medical Association (APMA) Seal of Acceptance for two of its therapeutic products.

Rite Aid to offer notes as part of refinancing

In line with a previously announced refinancing plan, Rite Aid Corp. aims to offer $400 million in senior secured notes due 2016.

CVS starts consumer ‘engine’

This quarter CVS Caremark Corp. is set to begin piloting its Consumer Engagement Engine, a data integration and intelligence solution designed to boost prescription drug adherence and effectiveness by providing a comprehensive view of the customer.

USA Drug flourishes with personal touch

The qualities that have enabled USA Drug to thrive as a regional chain were much in evidence at the opening of a relocated store here.

Court delays further action in AMP case

Both sides in the closely watched Medicaid average manufacturer price (AMP) case have asked the federal judge deciding the matter to delay further action until July 1.

NACDS: MTM needs to be part of health care reform

The prospects for meaningful health care reform are better than at any time since President Clinton’s first term, creating an opportunity for the National Association of Chain Drug Stores and its allies in community pharmacy to achieve two long-sought-after goals.